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Summary 
Understanding the immunological mechanismsof pro- 
tection and pathogenesis in tuberculosis remains 
problematic. We have examined the extent to which 
tumor necrosis factor-u (TNFu) contributes to this dis- 
ease using murine models in which the actlon of TNFa 
is inhibited. TNFa was neutralized in vlvo by mono- 
clonal antibody; in addition, a mouse strain with a dis- 
ruption in the gene for the 55 kDa TNF receptor was 
used. The data from both models established that 
TNFa and the 55 kDa TNF receptor are essential for 
protection against tuberculosis in mice, and for reac- 
tive nitrogen production by macrophages early in in- 
fection. Granulomas were formed in equal numbers 
in control and experimental mice, but necrosis was 
observed only in mice deficient in TNFa or TNF recep- 
tor. TNFa and the 55 kDa TNF receptor are necessary 
conditions for protection against murine M. fuberculo- 
sis infection, but are not solely responsible for the 
tissue damage observed. 
‘Present address: Institute Medical Microbiology and Hygiene, Techni- 
cal University of Munich, 61675 Munich, Federal Republic of Germany 
Introduction 
A fundamental question in tuberculosis is the extent to 
which pathogenesis is a function of the pathogen, Myco- 
bacterium tuberculosis, and to what extent it is a conse- 
quence of the immune responses of the host. M. tuberculo- 
sis induces a wide array of immune responses in the 
infected host. It is now clear that both CD4 and CD6 T 
cells contribute to the protective immune response to M. 
tuberculosis (Orme and Collins, 1964; Orme et al., 1992; 
Flory et al., 1992; Flynn et al., 1992). Macrophage activa- 
tion and, at least in murine models, reactive nitrogen inter- 
mediates (RNI) are central to the immune response 
against tuberculosis (Denis, 199la; Flesch and Kauf- 
mann, 1991; Chan et al., 1992). We and others have re- 
cently shown that mice that cannot produce interferon7 
(IFNy) (gko) (Dalton et al., 1993) are incapable of control- 
ling M. tuberculosis infection (Cooper et al., 1993; Flynn 
et al., 1993), and that this is correlated with a decrease 
in macrophage RNI production in these mice (Flynn et al., 
1993). 
Tumor necrosis factor-a (TNFa) is thought to be respon- 
sible for much of the pathology, including classic caseous 
necrosis, accompanying mycobacterial diseases (Rook et 
al., 1967; Rook, 1990). Previous studies by Kindler et al. 
(1969) showed that depletion of TNF by polyclonal anti- 
body blocked granuloma formation and impaired the 
ability of mice to localize infection with BCG (bacille Cal- 
mette-Guerin). Depletion of TNF by polyclonal antibody 
in BALBlc mice, which are fairly susceptible to M. tubercu- 
losis infection, reduced survival time, although the mice 
still survived up to 70 days postinfection (Denis, 1991 b). 
However, pathology and mechanisms of TNF action were 
not studied. Finally, infusion of TNFa was reported to in- 
crease resistance against M. tuberculosis (Denis, 1991 b) 
and Mycobacterium avium infection (Bermudez et al., 
1969) in mice. 
TNFa is produced by many cell types, including macro- 
phages, and is released when macrophages are exposed 
to lipopolysaccharide (LPS) or upon infection with a patho- 
gen (including mycobacteria). TNFa, with IFNy, induces 
the production of microbicidal RNI by macrophages 
(Flesch and Kaufmann, 1990; Liew et al., 1990; Chan et 
al., 1992). In the present experiments, we examine two 
models of murine tuberculosis in which the effect of TNFa 
is inhibited. In the first model, TNFa was neutralized by 
a monoclonal antibody (MAb); in the second, a transgenic 
mouse strain wasstudied in which the gene fortheTNFp55 
receptor was disrupted. The effects of TNFa on the course 
of infection with M. tuberculosis, pathology, and macro- 
phage activation were studied in these models. 
Results 
Depletion of TNF In Vivo by Anti-TNFa MAb Leads 
to a Lethal Course of M. tuberculosis Infectlon 
Our first approach to examine the role of TNFa in M. tuber- 
culosis infection was to treat infected C57BU6 mice with 
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Figure 1. Effect of TNF Neutralization or Lack of TNF ~55 Receptor 
on Survival of M. tuberculosis-Infected Mice 
C57BU6 mice treated with anti-TNF MAb (open triangle) or, as con- 
trols, hamster IgG (closed square), TNFRp55’ mice (open circle). 
Controls forTNFp55R-‘-(C57BU6 mice) showed 166% survival, identi- 
cal to hamster IgG-treated mice. Datashown are from twoexperiments 
each, with at least 6 mice per group per experiment. C57BU6 mice 
(open square) were previously immunized with BCG, and treated with 
anti-TNF MAb at time of challenge with M. tuberculosis. 
a hamster MAb, TN3-19.12, previously shown to neutralize 
murine TNFa in vivo (Bancroft et al., 1989; Sheehan et 
al., 1989; K. C. F. Sheehan and R. S., unpublished data). 
Anti-TNF MAb or hamster immunoglobulin G (IgG) were 
administered to mice (250 uglmouse, intraperitoneally) 1 
week prior to infection with virulent M. tuberculosis (5 x 
105, intravenously), and treatment was continued weekly 
following infection. TNFa-neutralized mice succumbed 
quickly to the infection, with a mean survival time of 
22 f 1 days (Figure 1). In contrast, control-infected mice 
treated with hamster IgG survived the length of the experi- 
ment (140 days). Neutralization of TNFa in uninfected 
mice had no obvious deleterious effects. Numbers of via- 
ble bacilli in the spleen, liver, and lungs were lo- to 1 OO-fold 
higher in the anti-TNF MAb-treated mice compared with 
IgG-treated mice (Figure 2). Thus, neutralization of TNFa 
impaired the ability of the relatively resistant C57BU8 
mouse strain to control replication of tubercle bacilli, re- 
sulting in a fatal infection. 
Mice Lacking TNF Receptor ~55 Rapidly Succumb 
to M. tuberculosis infection 
An alternative model for examining the contribution of TNF 
to the immune response against M. tuberculosis was pro- 
vided by a mouse strain with a disruption in the gene en- 
coding the 55 kDa TNF receptor (TNFRp55-I-) (Pfeffer et 
al., 1993). These mice, which have normal numbers of 
T and B cells, were previously shown to be resistant to 
LPS-mediated shock and were unable to resolve a Listeria 
monocytogenes infection (Pfeffer et al., 1993; Rothe et 
al., 1993) demonstrating that significant TNF-mediated 
biological effects were absent. 
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Figure 2. CFU in Spleen, Liver, and Lungs of M. tuberculosis-Infected 
Mice 
(A) C57BU6 mice treated with anti-TNF MAb (striped bar) or hamster 
IgG (shaded bar). 
(B) TNFRp55-‘- (striped bar) or control mice (shaded bar). Data shown 
are representative of two experiments, with at least three mice per 
time point. Error bars, SEM. 
TNFRp55+ and wild-type control mice (C57BU8) were 
infected with M. tuberculosis (5 x 105, intravenously). The 
TNFRp55-‘- mice were unable to control the infection and 
quickly succumbed (see Figure 1). Mean survival time 
postinfection for TNFRp55-‘- mice was 20 f 2 days, while 
control mice survived the length of the experiment. At 14 
days postinfection, there were lo- to 50-fold more bacilli 
in the organs of the TNFRp55+ mice, compared with the 
control mice (Figure 2). These data indicated that the 55 
kDaTNF receptor was required for control of M. tuberculo- 
sis infection and, together with the anti-TNF MAb experi- 
mental results, demonstrated that TNFa is essential to the 
protective immune response to this pathogen. 
Granuloma Formatlon in TNFa-Neutralized Mice 
In a previous study, neutralization of TNF in vivo by poly- 
clonal antibody to TNFa was reported to abolish granu- 
loma formation following infection with BCG (Kindler et 
al., 1989). Here, we examined the contribution of TNFa 
to granuloma formation during virulent M. tuberculosis in- 
fection in mice treated with a TNFa-neutralizing MAb. 
Granuloma formation did occur in all mice, but was de- 
layed in the anti-TNF MAb-treated mice, with fewer num- 
bers of granulomas seen in the liver and spleen at 7 days 
postinfection compared with control mice. However, by 
14 days postinfection, the numbers of granulomas were 
similar between anti-TNF MAb and IgG-treated mice (Fig- 
ures 3A, 38). While well-delineated granulomas con- 
taining epithelioid cells were observed in liver tissue from 
both groups of mice, approximately 20% of the granulo- 
mas in the TNF-neutralized mice appeared to lackepitheli- 
oidcells(Figures3A,38). In addition, thegranulomasseen 
in the TNF-depleted mice appeared less well organized 
than those of control mice. Spleen sections from both 
groups of mice revealed extensive granuloma formation, 
with the majority of granulomas in the anti-TNF MAb- 
treated mice containing epithelioid cells at 14 days postin- 
fection. In the liver and spleen sections from TNF- 
neutralized mice, numbers of acid-fast bacilli (AFB) were 
approximately lo- to 58fold higher than in sections from 
control mice. 
In terms of pathology, there were well-delineated granu- 
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lomas in lungs from both anti-TNF MAb- and IgG-treated 
mice at 14 days postinfection, but, in contrast with the 
IgG-treated control mice, the majority of the granulomas 
in the lungs of the anti-TNF-treated mice were necrotizing 
and contained overwhelming bacillary numbers (at least 
1 OO-fold more) (Figures 3E, 3F, 31,3J). Many of the bacilli 
appeared extracellular within the necrotic centers. In some 
cases, tuberculous pneumonia was observed, with ne- 
crotic tissue and large numbers of AFB eroding into the 
bronchioles. Although host cells, mainly lymphocytes, ap- 
peared to surround the infected macrophages, most of 
the granulomas did not appear to have activated macro- 
phages capable of containing and destroying the tubercie 
bacilli in the TNF-neutralized mice. 
Granuioma Formation in TNFRp5W Mice 
As in anti-TNF MAb-treated mice, tissues from M. tubercu- 
losis-infected TNFRp55-‘- mice showed a delay in granu- 
ioma formation relative to wild-type control mice. However, 
by 12 days postinfection, numbers of granuiomas in the 
lungs, liver, and spleen were essentially equivalent be- 
tween the TNFRp55+ and wild-type mice (Figures 3C, 
3D). As early as 5 days postinfection, granulomas were 
present in the liver and spleen tissue of TNFRp55-‘- and 
wild-type mice, but the granulomas differed markedly in 
appearance between the two groups. The granulomas in 
the wild-type mice were dispersed throughout the liver and 
spleen, were sharply circumscribed, and contained epi- 
thelioid cells. in contrast, the majority of granulomas (ap- 
proximately 8OW) from the TNFRp55-I- mice lacked epi- 
thelioid cells, and were more loosely organized. The 
percentage of granulomas lacking epithelioid cells was 
much higher in the TNFRp55-‘- mice compared with the 
anti-TNF MAb-treated mice. The numbers of AFB in the 
spleen and liver tissue were lo- to 50-fold higher in 
TNFRp55+ mice compared with control mice. 
Necrosis and lung pathology similar to that seen in the 
anti-TNF MAb-treated mice was observed in the 
TNFRp55+ mice. Many of the granulomas that had 
formed in the lung at 10 and 14 days postinfection were 
necrotizing, and filled with numerous AFB (Figures 3G, 
3H). Necrosis was not observed in control mice, and the 
numbers of AFB were 18 to 108fold lower in the lungs 
of the control mice compared with TNFRp55+ mice. The 
necrosis observed in the lung tissue of the TNFRp55-‘- 
mice was not asextensive as that observed in mice treated 
with anti-TNF MAb. 
Effect of TNFa Neutrslization or Lack of 55 kDa 
TNF Receptor on TNFa Transcription 
Previous studies using polyclonal anti-TNF antibody indi- 
cated that depletion of TNF with this antibody resulted in 
greatly diminished TNFa steady-state mRNA levels (Kin- 
dler et al., 1989). We examined levels of TNFa mRNA 
in M. tuberculosis-infected mice depleted of TNF, and in 
infected TNFRp55-‘- and wild-type mice, using a quantita- 
tive competitive RT-PCR protocol (Reiner et al., 1993). 
RNA was isolated from spleens and lungs of anti-TNF MAb 
or IgG-treated mice, TNFRp55+, and wild-type mice. Sim- 
ilar levels of TNFa-specific products were observed from 
RNA samples from all groups of mice (Figure 4), indicating 
that TNFa expression was occurring in the presence of 
anti-TNF MAb in vivo, and in the mice that lacked TNFp55 
receptor. To verify these results, Northern blot analysis 
was performed on spleen and liver RNA from anti-TNF 
MAb or IgG-treated mice, and the RNA was probed with 
a TNF-specific riboprobe. In contrast with the results of 
Kindler et al. (1989) the level of TNFa transcripts were 
similar in samples from mice treated with anti-TNF MAb 
compared with controls (data not shown), confirming that 
TNFa transcription was not significantly affected by treat- 
ment with anti-TNF MAb. The difference in our results may 
be due to increased TNFa transcription in M. tuberculosis 
versus BCG infections, or a reflection of the differences 
in the polyclonal and MAbs used. 
Reactive Nitrogen Intermediate Production 
by Macrophages from TNFRpSS’- Mice 
Production of nitric oxide and RNI by macrophages is cur- 
rently the only known mycobacteriocidai mechanism, and 
appears to be essential to control M. tuberculosis infection 
in mice. To address whether the inability of TNFRp55+ 
mice to control M. tuberculosis infection was correlated 
with a decrease in RNI production, spienic macrophages 
were obtained from TNFRp55” and wild-type mice at 10 
and 14 days postinfection. The macrophages were cul- 
tured for 48 hr in endotoxin-free media, and the superna- 
tants tested for the presence of nitrite (Figure 5). This 
“spontaneous” RNI production may be taken as an indica- 
tion of macrophage RNI production in vivo, as the macro- 
phages are not further stimulated in vitro. Macrophages 
from uninfected TNFRp55-‘- or wild-type mice did not pro- 
duce detectable RNI without in vitro stimulation (data not 
shown). Substantial spontaneous RNI production by mac- 
rophages from M. tuberculosis-infected wild-type mice 
was observed at 10 days postinfection. However, macro- 
phages obtained from TNFRp55-‘- mice at 10 days postin- 
fection produced very little RNI in the absence of in vitro 
stimulation. 
Although RNI production was diminished in TNFRp55-‘- 
mice early in infection, spienic macrophages from TNFR- 
p55-‘- mice obtained at 14 days postinfection showed in- 
creased spontaneous RNI production, comparable to 
macrophages from wild-type mice at this timepoint (Fig- 
ure 5). These data suggested that RNI production was 
delayed but not absent in TNFRp55-‘- mice during infec- 
tion with M. tuberculosis, and that as the infection pro- 
gressed, RNI production approached wild-type levels. 
Macrophages from the infected mutant and wild-type mice 
both produced RNI when stimulated with IFNy and LPS 
in vitro. However, in contrast with wild-type mice, no further 
stimulation of RNI production over spontaneous levels was 
observed when TNFRp55-‘- macrophages were stimu- 
lated with IFNy and TNFa. Uninfected macrophages from 
TNFRp55+ mice also produced levels of RNI similar to 
macrophages from wild-type mice when stimulated in vitro 
with IFNy and LPS, but little detectable RNI when TNFa 
was substituted for LPS (data not shown). These data indi- 
cate that induction of RNI production by TNFa proceeds 
through the55 kDaTNFreceptor, andsuggestthattheRN1 
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Figure 3. Pathology in TNF-Depleted or TNF Receptor-Deficient Mice Infected with M. tuberculosis 
(A-D) Liver sections stained with hematoxylin and eosin. Hamster IgG-treated (A)or anti-TNF MAb-treated (B) mice 16days postinfection. Magnifica- 
tion, 52 x Control (C) or TNFRp55-‘- (D) mice 14 days postinfection. Magnification, 104 x 
(E-H) Lung sections stained by the Ziehl-Neelsen method for AFB. Bacilli stain red (E, F). Hamster IgG-treated (E) or anti-TNF MAb-treated (F) 
mice 16 days postinfection. Control (G) or TNFRp55+ (H) mice 14 days postinfection. Magnification, 206x. 
(I-J) Lung sections from hamster IgG-treated mice (I) and anti-TNF MAb-treated (J) mice at 2 weeks postinfection. Sections are stained with 
hematoxyfin and eosin to show necrosis of lung tissue in TNF-neutralized mice. Magnification 52 x 
(K-N) Frozen lung sections at 10 (K, L) and 14 (M, N) days postinfection from control (K, M) and TNFRp55+- (L, N), immunostained with anti-iNCB 
antibody. Sections from at least six mice per timepoint, in two different experiments, were examined. A representative sample is shown. 
production seen at the later timepoints in M. tuberculosis 
infection in TNFRp55” mice is not attributable to TNFa 
production in vivo, but to induction via another molecule 
or mechanism. 
INOS Production in Lungs of TNFRp55-I- Mice 
In the above studies, we observed decreased RNI produc- 
tion in splenic macrophages from TNFRp55-‘- mice early 
in infection. The production of RNI in macrophages is de- 
pendent on the inducible form of the enzyme nitric oxide 
synthase (iNOS). As an extension of the above studies, 
we examined levels of iNOS in the lung immunohisto- 
chemically, using an antibody specific for INOS. Strong 
staining specifically in the granulomas was observed in 
wild-type mice 10 days postinfection, indicating the pres- 
ence of iNOS protein in the granulomas (see Figure 31). 
Although granulomas were present in the tissue, there 
was little detectable staining in the lung sections from 
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Figure 4. Quantitative Determination of TNFa mRNA Levels in Tis- 
sues from M. tuberculosis-Infected Mice 
Competitive quantitative RT-PCR on spleen tissue from anti-TNF MAb 
(a) and IgG (b) treated mice or TNFRp55+- (c) and control (d) mice. 
RNA was isolated from tissue obtained at 9 days postinfection, and 
reverse transcribed with random primers. cDNA levels were standard- 
ized by competitive PCR with HPRT primers, using a competitive DNA 
plasmid, as described previously (Reiner et al., 1993). Equivalent 
amounts of cDNA were used with a constant concentration of competi- 
tor DNA for the TNF-specific PCR reactions. Experiments were re- 
peated at least three times, on different RNA samples; a representative 
reaction for each sample is shown. 
TNFRp55-‘- mice at this timepoint (Figure 3J). How- 
ever, lung sections obtained from both wild-type and 
TNFRp55-‘- mice at 14 days postinfection showed essen- 
tially equivalent staining in the granulomas (Figures 3K, 
3L), indicating that iNOS expression in the lungs was simi- 
lar in mutant and wild-type mice at this later timepoint. 
Similar results were obtained with lung sections from mice 
treated with anti-TNF MAb. At 7 days postinfection, there 
was only minimal staining in the lungs of TNFa-neutralized 
mice, while lung sections from control (IgG-treated) mice 
showed strong staining. At 14 or 18 days postinfection, 
there was little difference in the staining pattern in lung 
tissue from the two sets of mice (data not shown). No 
staining was observed in lung tissue from uninfected mice, 
nor in lung sections from M. tuberculosis-infected gko 
mice (data not shown), which, as we showed previously, 
do not produce significant RNI or iNOS when infected 
(Flynn et al., 1993). The delay in lung iNOS expression in 
M. tuberculosis-infected TNFRp55-‘- and TNF-neutralized 
mice correlated with the decrease in splenic RNI produc- 
tion during the first 10 days of infection in these mice. 
Effect of TNF Depletion on BCG Immunization 
Against M. tuberculosis 
Immunization of mice with BCG results in a decreased 
bacterial burden in mice upon challenge with virulent M. 
tuberculosis. We have demonstrated a role for TNFa in 
the early response to M. tuberculosis infection. To exam- 
ine the requirement for this cytokine in established immu- 
nity, we immunized C57BU8 mice with BCG (1 x lo6 
bacilli, intravenously). Anti-TNF MAbor IgG were adminis- 
tered to the mice 8 weeks after immunization. The mice 
were challenged with virulent M. tuberculosis strain Erd- 
man (1 x lo6 bacilli, intravenously) and antibody treat- 
ment continued weekly. The immunized mice treated with 
10 14 
days post infection 
Figure 5. RNI Production by Macrophages Obtained from M. tubercu- 
losis-Infected TNFRp55+- Mice 
Splenic macrophages, recovered 10 and 14 days postinfection were 
either unstimulated in vitro (“spontaneous” release), or stimulated with 
rlFNy and LPS or TNFa. NO2 was measured in supernatents by Griess 
reagent, and compared with standard NaN02 curve. TNFRp5V un- 
stimulated (open bar), rlFNy plus LPS (thick striped bar), rlFNy plus 
TNFa (wavy lines bar). Wild-type unstimulated (closed bar), rlFNy plus 
LPS (thin striped bar), rlFNy plus TNFa (stippled bar). Error bars, SEM 
Datashown are from representative experiment repeated three times. 
anti-TNF MAb survived only 4-l 4 weeks postinfection (see 
Figure l), while the IgG-treated mice survived the length 
of the experiment (>20 weeks). This was in sharp contrast 
with unimmunized mice treated with anti-TNF MAb, which 
succumbed at 3 weeks postinfection. An increase in bacte- 
rial numbers in the anti-TNF MAbtreated immunized mice 
compared with IgG-treated immunized mice was not ob- 
served until 50-W days postinfection (Figure 8A). Thus, 
although BCG immunization prolonged survival even 
when TNFa was neutralized, TNFa was required for full 
protection against murine tuberculosis. 
Finally, because depletion of TNF by a polyclonal anti- 
body l-2 weeks after infection with BCG was reported to 
compromise severely the ability of mice to control BCG 
replication (Kindler et al., 1989), we thought it important 
to test the effect of the MAb TN3-19.12 on the course 
of BCG infection. Mice were treated with anti-TNF MAb 
beginning 1 week prior to infection with BCG (1 x lo6 
bacilli, intravenously); antibody treatments were contin- 
ued weekly for the length of the experiment (25 weeks). 
No differences in numbers of colony-forming units(CFU) in 
thespleen, liver, and lungs between anti-TNF MAb-treated 
mice and control mice at 2 weeks postinfection (Figure 
8B) were observed. A 5-fold increase in numbers of bacilli 
in the spleen and liver of the anti-TNF MAb-treated mice 
compared with control mice was observed at 7 weeks post- 
infection, but no difference in bacterial burden was de- 
tected in the lungs. All mice survived for the length of the 
experiment (25 weeks). Thus, neutralization of TNFa by 
MAb had minimal effects on the ability of the mice to con- 
trol BCG infection. 
Granuloma formation was previously reported to be im- 
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paired by polyclonal anti-TNF antibody treatment. We ob- 
served adelay in granuloma formation in the BCG-infected 
mice treated with anti-TNF MAb, in that at 2 weeks postin- 
fection, more granulomas were present in the liver of IgG- 
treated mice than in TNF-neutralized mice. However, 
granuloma formation in the TNF-neutralized mice was in- 
distinguishable from IgG-treated mice by 6 and 12 weeks 
postinfection, even though antibody treatment was contin- 
ued (Figure 7). Thus, in contrast with the results described 
by Kindler et al. (1989), where polyclonal antibody treat- 
ment resulted in the loss of granulomas during BCG infec- 
tion, we observed only a short delay in granuloma forma- 
27 27 27 
spleen liver lung 
weeks post-BCG infection 
Figure 6. Effect of TNF Neutralization on BCG Immunization 
(A) Effect of TNF neutralization on established immunity. C57BU6 
mice were immunized with BCG. Mice were treated 1 day prior to 
challenge with virulent M. tuberculosis with anti-TNF MAb (open circle) 
or IgG (closed square). CFU in spleen, liver, and lungs are shown at 
various times postinfection, from at least three mice per timepoint. 
(8) Effect of TNF neutralization on BCG infection. C57BU6 mice were 
treated with anti-TNF MAb (stiped bar) or IgG (closed bar) throughout 
the course of BCG infection. CFU in spleen, liver, and lungs were 
compared at 2 and 7 weeks postinfection, using at least three mice 
per timepoint. Error bars, SEM. 
tion in the TNF-neutralized mice compared with wild type. 
Only approximately lo%-20% of the granulomas in the 
TNF-neutralized BCG-infected mice appeared to lack epi- 
thelioid cells at the center of the granulomas, again in 
contrast with the results reported by Kindler et al. (1989; 
Figures 7C, 7D). 
Granuloma formation during BCG infection of TNFRp55I- 
mice was similar to wild-type mice. Few, if any, differences 
between the mutant and wild-type strains of mice could 
be detected, with respect to numbers and appearance of 
granulomas at 2, 3, and 5 weeks postinfection (data not 
shown). There was an increase (-5-fold) in numbers of 
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AFB in spleen sections from BCG-infected TNFRp55’- 
mice, compared with those from control mice at 5 weeks 
postinfection, but no differences observed in liver and 
lungs sections. Thus, lack of TNF signaling appeared to 
play only a minimal role in control of BCG infection, com- 
pared with a virulent mycobacterial infection. 
Discussion 
The aim of these studies was to elucidate the role of TNFa 
in protection and pathogenesis of tuberculosis. Two com- 
plementary approaches were undertaken: neutralization 
of TNFa in vivo by a MAb, and use of a genetically altered 
mouse strain that no longer expressed the 55 kDa TNF 
receptor. The results obtained from these murine models 
show that TNFa is essential to control and survival of M. 
tuberculosis infection in mice. In the absence of TNFa or 
the 55 kDa TNF receptor, mice infected with virulent M. 
tuberculosis succumbed rapidly, on average by 22 days 
postinfection, while the control micesurvived for the length 
of the experiment (140 days). Numbers of bacilli within 
the lungs, livers, and spleens of the TNF-neutralized or 
TNFRp55 gene-disrupted mice were at least lo-fold higher 
than in the control mice, and this difference could be de- 
tected as early as 7 days postinfection. Clearly, TNFa is 
required early in infection to limit replication of bacilli within 
the organs, and the lack of TNFa or TNF signaling via the 
55 kDa receptor leads to fatal infection. 
In studies using the avirulent mycobacterial strain, BCG, 
TNF was previously reported to be necessary for granu- 
loma formation (Kindler et al., 1989) which is thought to 
be required for localization and control of mycobacterial 
replication in tuberculosis. In both of the murine tuberculo- 
sis model systems described here, a delay in granuloma 
formation was observed. However, by 2 weeks postinfec- 
tion, there was little difference in numbers of granulomas 
seen in the mice deficient in TNFa or TNF receptor and 
controls. Nevertheless, the absence of TNFa or TNF sig- 
naling had a detrimental effect on the ability of granulomas 
to contain and restrict the replication of tubercle bacilli. 
The granulomas in the anti-TNF MAb-treated mice and 
TNFRp55-‘- mice contained greater numbers of bacilli than 
control mice. Finally, there was a marked qualitative differ- 
ence in the granulomas, in that those in TNFRp55-‘- mice 
were essentially devoid of epithelioid cells. This may indi- 
cate that signaling through the 55 kDa TNF receptor has 
an effect on monocyte migration to the granulomas, or 
on activation of the macrophages within the granuloma, 
although no effect on lymphocytic infiltration was ob- 
sewed. 
TNFa has been proposed as a major mediator of the 
pathology observed in tuberculous lesions (Rook et al., 
1987; Rook, 1990). Surprisingly, neutralization of TNFa 
by the MAb did not prevent necrosis in the lungs from 
occurring as the bacterial burden increased. Extensive 
necrosis wasalsoobserved in the lungsof mice that lacked 
the 55 kDa TNF receptor. The necrosis was initially con- 
fined to the granulomas, but quickly expanded to involve 
large areas of the lungs, and the bacilli originally contained 
in the granulomas later appeared extracellular. Necrotic 
granulomas were not obsewed in control mice. In the anti- 
TNF MAb model, lung tissue necrosis was more prominent 
than that seen in the TNFRp55-I- mice, but, in contrast 
with the TNFRp55-‘- mice, necrosis was not observed in 
liver or spleen tissue from TNF-neutralized mice. These 
results indicate that TNFa is not solely responsible for the 
necrosis seen during tuberculosis. Cytokines other than 
TNFa, such as interleukin-1 (IL-l) or TNFj3, could contrib- 
ute to necrosis and pathology. TNF8 is not neutralized by 
the MAb used in these studies. In addition, necrosis may 
be due to products of increased number of bacilli in the 
tissues or the production of a cytolytic factor by M. tubercu- 
losis. However, TNFa cannot be formally excluded from 
causing the necrosis seen, since in both model systems 
the gene for TNFa is still expressed at levels similar to 
control mice, and thus TNFa is likely produced in normal 
amounts. In the anti-TNF MAb-treated mice, the presence 
of large numbers of bacilli may increase TNFa production 
by macrophages beyond the levels that can be neutralized 
by the antibody, although we did not observe such in- 
creases in TNFa gene mRNA levels. In the mice that lack 
the 55 kDa receptor, it cannot be excluded that necrosis 
might be mediated by TNFa interacting with the 75 kDa 
receptor or by TNF8 via the unique TNF8 receptor (Crowe 
et al., 1994). 
Macrophage activation is a key component of the protec- 
tive immune response to M. tuberculosis infection. The 
only demonstrated mechanism by which macrophages kill 
virulent tubercle bacilli is activation by IFNy and LPS or 
TNFa to produce RNI (Denis, 1991a; Flesch and Kauf- 
mann, 1991; Chan et al., 1992). Like IFNy, TNFa may 
be required for early RNI production. We found that RNI 
production was delayed but not absent in infected 
TNFRp55” and TNF-neutralized mice, both in splenic 
macrophages and in the lung granulomas. It is possible 
that this delay in RNI production is responsible for the 
inability of the TNFRp55-‘- and TNF-neutralized mice to 
control the infection. Without macrophage activation im- 
mediately upon infection, the bacilli could multiply to a 
level that overwhelms any mycobacteriocidal mecha- 
nisms. The effect of TNF depletion or lack of receptor may 
be equivalent to an increased challenge inoculum, which 
in immunocompetent C57BL18 mice leads to a fatal 
infection. 
The delay in RNI production in TNFRp55-‘- mice could 
be due to the direct effect of TNFa (with IFNr) on iNOS 
expression, or to the effect of TNFa on IFNy production 
by natural killer cells in the early phases of the infection. 
Figure 7. Effect of TNF Neutralization on Granuloma Formation in BCG-Infected Mice 
Liver sections stained with hematoxylin and eosin at 6 weeks postinfection with BCG. Hamster IgG treated mice (A, C); anti-TNF MAt-treated 
mice (6. D). Magnification, 166x (A, B); 336x (C, D). 
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Our results do not distinguish between these two possibili- 
ties. However, our results do indicate that TNFa and sig- 
naling through the 55 kDa TNF receptor is not absolutely 
required for iNOS expression or RNI production in vivo. 
In vitro, the mycobacterial equivalent of LPS, lipoarabino- 
mannan, can act with IFNy to induce RNI production 
(Roach et al., 1993). Macrophages from mice lacking the 
55 kDa TNF receptor can be stimulated to produce RNI 
by IFNy and LPS, but not by IFNy and TNF. In our model, 
we suggest that lipoarabinomannan, which increases as 
the mycobacterial burden increases, may signal or acti- 
vate an alternate pathway, which activates iNOS produc- 
tion. Thus, the increase in RNI production at the latertime- 
points in infection could be attributed to the rise in 
mycobacterial lipoarabinomannan production. Alterna- 
tively, another cytokine that is induced at a later point in 
the infection may induce iNOS expression. Clearly, TNFa 
could also affect other metabolic or mycobacteriocidal 
mechanisms, besides RNI. If the late production of RNI 
was induced by products of organisms that had grown to 
high levels in the granulomas, it is not impossible that 
the RNI produced could contribute to the pathogenesis, 
specifically to necrosis. 
Although we have presented data that suggest that 
TNFa is required early in infection for the successful im- 
mune response to this pathogen, there is also evidence 
that TNFa plays a role in established immunity. Mice im- 
munized with BCG, and then treated with anti-TNFa MAb 
at the time of challenge with virulent M. tuberculosis, sur- 
vived much longer than unimmunized TNF-neutralized 
mice. Nevertheless, the anti-TNF MAb-treated immunized 
mice eventually succumbed to the virulent challenge, with 
increased bacterial numbers, indicating that TNFa is re- 
quired to maintain established immunity. 
When the effects of TNFa neutralization by MAb on the 
course of BCG infection were examined, in contrast with 
the studies of Kindler et al. (1989), we found only minimal 
effects on growth of BCG, and no effect at all on survival 
of mice infected with BCG. We also observed comparable 
granuloma formation and appearance in the TNF-neutral- 
ized and control mice. In addition, granuloma formation 
was similar in BCG-infected TNFRp55-I- and control mice. 
The reasons for this discrepancy remain unclear, but may 
be linked to the difference in antibodies used in the two 
studies. Thus, our results indicate that in the absence of 
TNFa-mediated signaling, granulomas still form in re- 
sponse to mycobacterial infection. However, at least with 
virulent M. tuberculosis infection, macrophages within the 
granulomaappear not to be activated to destroy the bacilli. 
The results reported here from two different murine mod- 
els establish that TNFa and the 55 kDa TNF receptor play 
an essential protective role in the immune response in 
mice to M. tuberculosis infection. This role may be related 
to macrophage activation and the subsequent destruction 
of intracellular bacilli, by RNI, or alternate mechanisms. 
In any case, it is clear that the in vivo effects of TNFa on 
resistance to M. tuberculosis infection are mediated and 
signaled via the 55 kDa TNF receptor and TNFRp55- 
induced systems. Although TNFa has been implicated in 
the pathology of tuberculosis, our data indicate that TNFa 
and the 55 kDa TNF receptor are not necessary conditions 
for necrosis in infected host tissue and that other factors, 
produced either by host or pathogen, may contribute to 
tissue damage. 
Experimental Procedures 
MiCD 
Female C57BU6 mice, 6-10 weeks of age, were purchased from Jack- 
son Laboratories (Bar Harbor, Maine). TNFRp55? mice were bred 
as homozygotes in specific pathogen-free facilities at Albert Einstein 
College of Medicine. The mice were routinely tested and found to be 
free of the 12 common mouse pathogens. The TNFRp55’ mice were 
backcrossed (three times) onto the C57BU6 background. Previous 
studies (Flynn et al., 1992, 1993; J. L. F., unpublished data) demon- 
strated no discernible differences between C57BU6 and any of the 
gene-disrupted heteroxygote mice tested with respect to infection. In 
addition, 129Sv mice and C57BU6 x 129Sv Fl mice have similar 
infection profiles as C57BU6 mice (J. L. F., unpublished data). 
Bacterial Strains and Infections 
Virulent M. tuberculosis (strain Erdman, Trudeau Institute, Saranac 
Lake, New York) was passed through mice, grown in culture once, 
and frozen in aliquots. BCG strain Pasteur 1192 was also obtained 
from Trudeau Institute, and stored in frozen aliquots. Before injection 
into mice, an aliquot was thawed, diluted in phosphate-buffered saline 
containing 0.05% Tween 60, and sonicated for 10 s in a cup-horn 
sonicator. Mice were infected intravenously via tail vein with 5 x IOJ 
or 1 x 10 live bacilli (as indicated in text) in 100 ul, as determined by 
viable counts on 7HlO agar plates (Difco Laboratories, Incorporated. 
Detroit, Michigan). Regardless of genetic background or strain muta- 
tion, we have found that the numbers of bacilli in the organs at 24 
hr postinfection are consistent. In mice infected with 10 viable M. 
tuberculosis bacilli, at 24 hr postinfection we find 1.6 x 105 f 2.7 x 
104 CFU in the spleen, 1.1 x lo8 f 1.2 x lo6 CFU in the liver, and 
6.7 x IO3 f 1.5 x IO3 CFU in the lungs (16 mice per group). 
Anti-TNF MAb 
Preparation and characterization of hamster anti-murine TNF MAb 
TN3-19.12 have been described elsewhere (Sheehan et al., 1969). 
Recent data from experiments using recombinant murine TNFa and 
TNF5 revealed that this antibody reacts with and neutralizesonly TNFa 
(K. C. F. Sheehan and R. S., unpublished data). The MAb was affinity 
purified on protein A-sepharose and contained less than 25 pg endo- 
toxinlmg protein, as previously described (Sheehan et al., 1969). Ham- 
ster IgG was obtained from Jackson lmmunochemicals (West Grove, 
Pennsylvania). 
Bacterial Number Determlnatlon 
Organs retrieved from infected mice were homogenized in phosphate 
buffered saline, Tween 60 (0.05%) in plastic bags using a Stomacher 
homogenizer (Tekmar Copany, Cincinnati, Ohio), diluted, and plated 
on supplemented 7HlO media (Difco Laboratories, Incorporated, De- 
troit, Michigan). Colonies were counted after 21 days incubation at 
37OC. At least three mice per timepoint were sacrificed for CFU deter- 
mination. 
Histology 
Tissues were fixed in 10% formalin and embedded in paraffin blocks. 
Sections (5 pm) were stained with hematoxylin and eosin (H and E) 
or by the Ziehl-Neelsen method for AFB. 
RT-PCR 
Spleen and lung tissue samples from infected mice were frozen in 
liquid nitrogen and stored at -6OOC. RNA was extracted using asingle 
step method (Chomczynski and Sacchi, 1967). Any residual DNA was 
removed by DNAse, followed by phenol-chloroform extraction and 
ethanol precipitation. RNA(5 ug) was reverse transcribed using Super- 
Script II reverse transcriptase (GIBCO BRL); cDNA was then diluted 
l:lO, and used in quantitative PCR reactions with a polycompetitor 
plasmid DNA, as described (Reiner et al., 1993). In brief, cDNA from 
each sample was standardized in competitive quantitative PCR reac- 
TFNa Is Essential for Protection Against Tuberculosis 
571 
tions with hypoxanthine-guanine phosphoribosyl transferase (HPRT)- 
specific primers andvarying amountsof competitor DNA. Based on the 
standardization, identical amounts of cDNA were used in subsequent 
TNF-specific PCR reactions, using a constant concentration of com- 
petitor plasmid in each reaction. Reactions were electrophoresed on 
agarose gels, stained with ethidium bromide, and photographed. The 
upper band(s) corresponds to the plasmid DNA, while the lower band 
to the cDNA. 
Immunohletochemiatry 
Fresh lung tissue was embedded in CCT (Miles, Incorporated), flash- 
frozen in liquid nitrogen, and stored at -60°C. Sections (5 micron) 
were cut using a cryostat, air dried 20-30 min, and fixed in acetone. 
Sections were blocked with 1% goat serum in phosphate-buffered 
saline for 1 hr and incubated with rabbit polyclonal anti-iNOS antibody 
(1:lOO dilution) for 2 hr. Secondary antibody was biotinylated goat 
anti-rabbit IgG (Vector Laboratories). Staining was by the avidin-bio- 
tin-peroxidase complex method with diaminobenzidine as substrate. 
Sections were counterstained with hematoxylin. No staining was ob- 
sewed in uninfected miceor in the absenceof primary antibody. Rabbit 
polyclonal anti-iNOS peptide antibody was produced using methods 
previously described (Harlow and Lane, 1966; Bredt et al., 1990). In 
brief, a peptide corresponding to the carboxy-terminal 15 aa of iNOS 
(Lowenstein et al., 1992) was synthesized (AKKGSALEEPKATRL) and 
coupled to thyroglobulin. The conjugate was injected with complete 
Freund’s adjuvant into a New Zealand white rabbit. A booster injection 
was repeated at monthly intervals, and serum was collected 1 week 
after boosting (Hazelton Research, Incorporated, Denver, Pennsylva- 
nia). The antibody was purified from the serum using an affinity column 
of peptide conjugated to bovine serum albumin (Harlow and Lane, 
1988). 
Macrophage RNI Aeeeys 
Spleen cells were obtained from wild-type and TNFRp55-‘- mice at 10 
and 14 days postinfection by crushing spleens in mesh bags. Red 
blood cells were lysed using Tris-buffered ammonium chloride. After 
washing twice, cells were plated at 4 x IQ cells per well in 96well 
plates in DMEM supplemented with 10% fetal bovine serum, 5% 
NCTClO9, and 1% nonessential aminoacids. Cellswereeither unstim- 
ulated or stimulated with IFNy and LPS or IFNy and TNF. For stimu- 
lated cultures, rlFNT (250 U/ml, Genentech) was added at initial seed- 
ing,withLPS(l ug/ml,Sigma)orTNF(4OOOU/ml, Boehringsr-Mannheim) 
added 16 hr later. Supernatants were collected 46 hr after seeding, 
filtered, and nitrite was measured by the Griess assay, as previously 
described (Chan et al., 1992). In some experiments, nonadherent cells 
were removed after 4 hr, and nitrite production by adherent cells mea- 
sured; no significant differences were observed in nitrite production 
by total spleen cells or adherent cells. 
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